Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hongliang (Shanghai) Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Hongliang (Shanghai) Biomedical Technology Co., Ltd.
100 Deals associated with Hongliang (Shanghai) Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Hongliang (Shanghai) Biomedical Technology Co., Ltd.